Related Experiment Videos
Leukemia-inhibitory factor-neuroimmune modulator of endocrine function
1Academic Affairs, Cedars-Sinai Research Institute, University of California Los Angeles School of Medicine, 90048, USA.
Endocrine Reviews
|June 17, 2000
Summary
Leukemia-inhibitory factor (LIF) is a cytokine involved in many bodily functions. This review details LIF
Area of Science:
- Endocrinology
- Molecular Biology
- Cytokine Signaling
Background:
- Leukemia-inhibitory factor (LIF) is a pleiotropic cytokine with diverse biological activities.
- LIF signaling involves the gp130 receptor subunit and JAK-STAT pathways, regulated by SOCS and PIAS proteins.
Purpose of the Study:
- To review recent advances in LIF expression and action mechanisms.
- To provide a systemic overview of LIF-mediated endocrine regulation.
Main Methods:
- Literature review of recent scientific publications on Leukemia-inhibitory factor.
- Analysis of molecular mechanisms regulating LIF expression and signaling pathways.
Main Results:
- LIF plays critical roles in endocrine functions, including the utero-placental unit, hypothalamo-pituitary-adrenal axis, bone metabolism, and energy homeostasis.
- LIF integrates developmental and functional cell signals to maintain hormonal and metabolic homeostasis.
Conclusions:
- LIF acts as a crucial molecular interface between neuroimmune and endocrine systems.
- Understanding LIF's role is vital for comprehending hormonal and metabolic regulation.